Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02189018 · ClinicalTrials.gov registry record · NA
Activity To Improve Outcomes in Peripheral Arterial Disease
A NA study of Peripheral Arterial Occlusive Disease, sponsored by Baltimore VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT02189018: Completed NA study of Peripheral Arterial Occlusive Disease, sponsored by Baltimore VA Medical Center.
NCT02189018 is a NA study of Peripheral Arterial Occlusive Disease that has completed, run by Baltimore VA Medical Center. The registered enrollment target is 208 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02189018, a NA study of Peripheral Arterial Occlusive Disease, has completed, sponsored by Baltimore VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
Peripheral artery disease (PAD) results in blockages of arteries (blood vessels) in the legs and decreased blood flow to the legs. This may cause difficulty or pain with walking or other activities that use leg muscles. Exercise may help improve blood flow in the legs and improve the ability to walk. This research project is being implemented in adults with PAD to examine the effects of exercise or weight loss programs on lower extremity blood flow, health, and physical function.
Primary Outcome
Ankle brachial index and ultrasound quantification of muscle perfusion
Conditions Studied
Interventions
- OTHER Active Exercise
- OTHER Neuromuscular electrical stimulation
- OTHER Weight loss and active exercise
- OTHER Ad lib activity at home
Study Locations (1)
Maryland
- Baltimore VAMC - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2014-08 |
| Est. Completion | 2023-07-04 |
| Phase | NA |
What the finished NCT02189018 record still lists
NCT02189018 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Peripheral Arterial Occlusive Disease appearing as the primary indexed condition, and to 4 interventions - of which Active Exercise is the first listed.
NCT02189018 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02189018 about?
NCT02189018 is a clinical study titled "Activity To Improve Outcomes in Peripheral Arterial Disease". Peripheral artery disease (PAD) results in blockages of arteries (blood vessels) in the legs and decreased blood flow to the legs. This may cause difficulty or pain with walking or other activities that use leg muscles. Exercise may help improve blood flow in the legs and improve the ability to walk...
What is the current status of trial NCT02189018?
This trial is currently completed. It is a NA study. The enrollment target is 208 participants. The study started on 2014-08. Estimated completion is 2023-07-04.
What conditions does trial NCT02189018 study?
This clinical trial studies the following conditions: Peripheral Arterial Occlusive Disease.
What interventions are being tested in trial NCT02189018?
The interventions under investigation include: Active Exercise (OTHER), Neuromuscular electrical stimulation (OTHER), Weight loss and active exercise (OTHER), Ad lib activity at home (OTHER).
Who is sponsoring clinical trial NCT02189018?
This trial is sponsored by Baltimore VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02189018 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Occlusive Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02189018's enrollment target sits among peer trials
208 496th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia